Document is current
Any future updates will be listed below
-
Authors
Zhang, Weiruo
Li, Irene
Reticker-Flynn, Nathan E.
Good, Zinaida https://orcid.org/0000-0003-2343-5771
Chang, Serena
Samusik, Nikolay
Saumyaa, Saumyaa
Li, Yuanyuan
Zhou, Xin https://orcid.org/0000-0003-4015-4787
Liang, Rachel
Kong, Christina S.
Le, Quynh-Thu
Gentles, Andrew J. https://orcid.org/0000-0002-0941-9858
Sunwoo, John B. https://orcid.org/0000-0002-8393-4196
Nolan, Garry P. https://orcid.org/0000-0002-8862-9043
Engleman, Edgar G.
Plevritis, Sylvia K.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA209971)
Parker Institute for Cancer Immunotherapy at San Francisco, CA, USA, and Stanford Cancer Institute, CA, USA
Tobacco-Related Disease Research Program (T31IP1598)
Tobacco-Related Disease Research Program (T31IP1598)
- License Information
-
More Information
Article History
Received: 14 April 2021
Accepted: 15 April 2022
First Online: 2 June 2022
Competing interests
: Z.G. is an inventor on two patent applications and an investor in Boom Capital Ventures, and a consultant for Mubadala Ventures, GLG and Atheneum Partners. Q.-T.L. has received grants from Varian and serves as a consultant for Nanobiotix, Coherus, Merck and Roche. All other authors have no competing interests.
